Janta, Pannipa
Vimolmangkang, Sornkanok
Funding for this research was provided by:
National Science, Research and Innovation Fund (B13F660137, B13F660137)
Article History
Received: 26 June 2024
Accepted: 25 November 2024
First Online: 6 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: Sornkanok Vimolmangkang reports equipment, drugs, or supplies were provided by Leapdelab Co., Ltd. The corresponding author is the CEO of Leapdelab Co., Ltd., providing some materials for analysis in the study. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.